Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997–2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999–2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs.
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2012 |
| Reihe/Periodikum: | Emerging Infectious Diseases, Vol 18, Iss 9, Pp 1515-1518 (2012) |
| Verlag/Hrsg.: |
Centers for Disease Control and Prevention
|
| Schlagwörter: | Group A streptococcus / antibiotic resistance / fitness costs / macrolide use / macrolides / erm(A) / Medicine / R / Infectious and parasitic diseases / RC109-216 |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26612561 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://doi.org/10.3201/eid1809.120049 |
